|
|||||
|
|
Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor |
|
| Authors: | Nichols Alice I Tourian Karen A Tse Susanna Y Paul Jeffrey |
| Affiliation: | Pfizer, Inc., (formerly Wyeth Research), Collegeville, PA 19426, USA. Alice.Nichols@pfizer.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |